Page 6 - John Sperzel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

T2 Biosystems (TTOO) announces preliminary Q3 total revenue of $1 5 million

T2 Biosystems (TTOO) announces preliminary Q3 total revenue of $1 5 million
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

John sperzelFinancial outlookthe companyBacteria panelBiothreat panelNasdaq listing statusthe companyResistance panelBiosystems incThird quarterOutlookthe companyListing statusthe company

T2 Biosystems Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel to Include Detection of Acinetobacter baumannii

12.10.2023 - LEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) - T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has submitted a 510(k) premarket . Seite 1

John sperzelWorld health organizationBacteria panel

T2 Biosystems Receives FDA 510(k) Clearance for the T2Biothreat Panel

T2 Biosystems Receives FDA 510(k) Clearance for the T2Biothreat Panel
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJohn sperzelUs department of healthBiothreat panelWhile the companyBiomedical advanced researchHuman servicesPublic healthUs centers for diseaseOchsner medical centerAdministration for strategic preparednessGilmartin groupBiosystems incExchange commissionPublic health emergency medical countermeasures enterpriseCompany annual report on form

T2 Biosystems Praises CDC s Actions Aimed at Optimizing U S Hospital Sepsis Programs - T2 Biosystems (NASDAQ:TTOO)

LEXINGTON, Mass., Aug. 28, 2023 (GLOBE NEWSWIRE) T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today praised actions taken by the

United statesJohn sperzelMandy cohenUs centers for diseaseBiosystems incWhile the companyCompany annual report on formHospital sepsis program core elementsExchange commissionDisease controlHospital leadership commitmentMulti professional expertisePrivate securities litigation reform actAnnual reportQuarterly reportsCurrent reports

T2 Biosystems touts highly differentiated products in fight against sepsis

T2 Biosystems has been attracting meme-stock-like buzz recently.

John sperzelBiosystems incAlliance global partnersSidoti micro cap conferenceSidoti micro capGlobal partnersArticle normalMedical equipment suppliesHealthcare life sciencesMedical diagnostic equipment suppliesMedical devices apparatusDiagnostic therapeutic devicesFinancial performanceShare price movement disruptionsCorporate industrial newsContent types